Decreased cholesterol synthesis and resultant hypocholesterolemia is hypothesized as an early marker of liver disease, as it is associated with liver fibrosis even without correlative transaminases or gamma-glutamyl transpeptidase (GGT) elevation. This evidence concerns the gene GGTLC1 and liver disorder.